SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-23-135977
Filing Date
2023-05-04
Accepted
2023-05-04 16:31:10
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d557482d424b5.htm 424B5 443881
2 GRAPHIC g557482g04a96.jpg GRAPHIC 593583
3 GRAPHIC g557482g38j86.jpg GRAPHIC 35150
4 GRAPHIC g557482g90e15.jpg GRAPHIC 152220
  Complete submission text file 0001193125-23-135977.txt   1509229
Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics, Inc. (Filer) CIK: 0001650648 (see all company filings)

IRS No.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-263925 | Film No.: 23889309
SIC: 2836 Biological Products, (No Diagnostic Substances)